Loading...
MedRx Co., Ltd
4586.T•JPX
Healthcare
Drug Manufacturers - Specialty & Generic
¥74.00
¥0.00(0.00%)
MedRx Co., Ltd (4586.T) Financial Performance & Income Statement Overview
Review MedRx Co., Ltd’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
786.21%
↑ 786.21%
Operating Income Growth
15.005%
↑ 15.005%
Net Income Growth
13.52%
↑ 13.52%
Operating Cash Flow Growth
12.05%
↑ 12.05%
Operating Margin
-399.18%
↓ 399.18%
Gross Margin
88.32%
↑ 88.32%
Net Profit Margin
-426.26%
↓ 426.26%
ROE
-49.16%
↓ 49.16%
ROIC
-59.94%
↓ 59.94%
MedRx Co., Ltd (4586.T) Income Statement & Financial Overview
Review MedRx Co., Ltd's (4586.T) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $2.00M | $24.00M | $231.48M | $0.00 |
| Cost of Revenue | $9.47M | $0.00 | $11.04M | $11.04M |
| Gross Profit | -$7.47M | $24.00M | $220.43M | -$11.04M |
| Gross Profit Ratio | -$3.73 | $1.00 | $0.95 | |
| R&D Expenses | $0.00 | $0.00 | $124.71M | $110.63M |
| SG&A Expenses | $406.72M | $267.00M | $55.26M | $176.00M |
| Operating Expenses | $416.00M | $268.00M | $179.97M | $176.08M |
| Total Costs & Expenses | $416.00M | $268.00M | $191.01M | $176.08M |
| Interest Income | $0.00 | $0.00 | $7000.00 | $10000.00 |
| Interest Expense | $0.00 | $0.00 | $1.59M | $144000.00 |
| Depreciation & Amortization | $9.17M | $11.25M | -$1000.00 | $11.25M |
| EBITDA | -$404.50M | -$231.75M | $40.46M | -$164.75M |
| EBITDA Ratio | -$202.25 | -$9.66 | $0.17 | |
| Operating Income | -$414.00M | -$244.00M | $40.47M | -$176.08M |
| Operating Income Ratio | -$207.00 | -$10.17 | $0.17 | |
| Other Income/Expenses (Net) | -$66.00M | -$14.00M | $23.15M | $48.27M |
| Income Before Tax | -$480.00M | -$258.00M | $63.62M | -$127.81M |
| Income Before Tax Ratio | -$240.00 | -$10.75 | $0.27 | |
| Income Tax Expense | $6.00M | $1.00M | -$3.65M | $459000.00 |
| Net Income | -$486.00M | -$259.00M | $67.26M | -$128.27M |
| Net Income Ratio | -$243.00 | -$10.79 | $0.29 | |
| EPS | -$10.25 | -$5.64 | $1.53 | -$3.33 |
| Diluted EPS | -$10.25 | -$5.64 | $1.53 | -$3.33 |
| Weighted Avg Shares Outstanding | $47.42M | $45.91M | $43.95M | $38.52M |
| Weighted Avg Shares Outstanding (Diluted) | $47.42M | $45.91M | $43.95M | $38.52M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan